Skip to main content
SpringerLink
Log in

Topiramate has an important, adjunctive role in childhood epilepsy

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ormrod D, McClellan K. Topiramate. A review of its use in childhood epilepsy. Paediatr Drugs 2001; 3(4): 293–319

    Article  PubMed  CAS  Google Scholar 

  2. Culy CR, Goa KL. Lamotrigine. A review of its use in childhood epilepsy. Paediatr Drugs 2000 Jul–Aug; 2(4): 299–330

    Article  PubMed  CAS  Google Scholar 

  3. Natsch S, Hekster YA, Keyser A, et al. Newer anticonvulsant drugs. Role of pharmacology, drug interactions and adverse reactions in drug choice. Drug Safety 1997 Oct; 17(4): 228–40

    Article  PubMed  CAS  Google Scholar 

  4. British National Formulary. No. 41. London: The Pharmaceutical Press, 2001 Mar: 224-33

  5. Sabers A, Gram L. Newer anticonvulsants. Comparative review of drug interactions and adverse effects. Drugs 2000 Jul; 60(1): 23–33

    Article  PubMed  CAS  Google Scholar 

  6. Physicians’ Desk Reference 2001, 55th ed. Montvale, NJ: Medical Economics Company, Inc., 2001

  7. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999 Apr 22; 52: 1338–44

    Article  PubMed  CAS  Google Scholar 

  8. Ritter F, Glauser TA, Elterman RD, et al. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group. Epilepsia 2000; 41 Suppl. 1: S82–5

    Article  PubMed  CAS  Google Scholar 

  9. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999 Apr 22; 52: 1330–7

    Article  PubMed  CAS  Google Scholar 

  10. Food and Drug Administration Center for Drug Evaluation and Research. Topamax Sprinkle (Topiramate) Capsules: application no. 20844/S001. Medical review(s). Updated 2000 Jun 30. Available from URL: http://www.fda.gov/cder/foi/nda/99/20844S1_Topomax.htm [Accessed 2000 Oct 5]

  11. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999 Jun 10; 52: 1882–7

    Article  PubMed  CAS  Google Scholar 

  12. Anon. US market new. InPharma 2001 Sep 8; (1304): 22

  13. Riviello Jr JJ, Wheless J, Wu SC, et al. Body weight changes during topiramate therapy in children with epilepsy [abstract]. Epilepsia 1999; 40 Suppl. 7: 127

    Google Scholar 

  14. Pellock JM. Treatment of seizures and epilepsy in children and adolescents. Neurology 1998; 51 Suppl. 4: S8–14

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topiramate has an important, adjunctive role in childhood epilepsy. Drugs Ther. Perspect 17, 1–5 (2001). https://doi.org/10.2165/00042310-200117230-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117230-00001

Keywords

Search

Navigation